Site Search
Search Results
Some Patients Lack Access to Lower-cost Drug Alternatives
The Problem Many cancer patients take multiple drugs as part of their treatment – often for many months or years. While drugs are not the only costly part of cancer treatment, finding ways to reduce these costs for patients and payers will significantly reduce the overall cost burden of cancer. Biosimilars and generics are lower cost alternative versions to some cancer drugs that may become available after the ... and her insurer nearly $75,000 over two years. If she had access to a biosimilar, those overall costs would have decreased by over 20%. ACS CAN Fights for Solutions ACS CAN supports efforts to ensure biosimilar and generic drugs are available to patients either through prescription from ...
Survivor Views: Surprise Billing and Prescription Cost and Coverage Survey Findings Summary
Overview: The American Cancer Society Cancer Action Network (ACS CAN) established Survivor Views in January 2019. The project has established a cohort of 3,055 cancer patients and survivors diagnosed with and/or treated for cancer within the last five years who are willing to share their opinions ... In October 2019, Survivor Views conducted a cohort survey focused on their experiences accessing and paying for cancer care, including the cost of prescription drugs and their experiences receiving surprise bills. One thousand three hundred and ninety-two cohort members responded to ...
ACS CAN Factsheet: State Data on Health Care Tax Credits
... those who do not yet know they have cancer) need. Enrollees in Marketplace plans have access to evidence-based preventive services (without any cost sharing), prescription drug coverage, a network of doctors (including specialists like oncologists), emergency services, laboratory services, and other services cancer patients need. This factsheet provides data on the percentage and number of people in each state enrolled in a Marketplace plan. ACS CAN Factsheet: State Data on Health Care Tax Credits ...
Survivor Views: Copay Assistance and Patient Navigation
Overview: The American Cancer Society Cancer Action Network (ACS CAN) gives voice to cancer patients and survivors on critical public policy issues that affect their lives. As part of this effort, ACS CAN deploys surveys to better understand cancer patient and survivor experiences and perspectives, through our Survivor Views ... populations, with over one-quarter of Black, Hispanic, and Asian cancer patients and survivors reporting they have declined treatment due to cost after finding they were unable to enroll in a copay assistance program. The most difficult tasks for cancer patients and survivors tend to be ...
Understanding Biologic and Biosimilar Drugs
Biologics basics Biological drugs, commonly referred to as biologics, are a class of drugs that are produced using a living system, such as a microorganism, plant cell, or animal cell. Like all drugs, biologics are regulated by ... Biologics have been a part of medical treatment for a long time and have been used for treating cancer since the 1980s. Biologics can be used to treat cancer in a variety of ways. One way, immunotherapy, helps the body’s own immune system fight cancer cells. Other ... were introduced Biosimilars were introduced to the market in an effort to increase competition and reduce drug costs. In general, biologics cost more to develop and manufacture than small molecule drugs. They also take a longer time to bring to market (10 to 15 years versus 7 to 10 ...